Reimbursement In Brief
This article was originally published in The Gray Sheet
Executive Summary
Labs cite problems with molecular diagnostics payment-setting process. PCORI panels include device, diagnostic appointees. More reimbursement news.
You may also be interested in...
HHS OIG Expects Almost $4 Billion In Recoveries From First Half Of Fiscal 2013
Its spring 2013 Semiannual Report to Congress says the Office of Inspector General expects recoveries of about $3.8 billion from audits and investigations undertaken in the first half of fiscal year 2013, among other findings.
Molecular Dx Labs Fret Over Medicare Payment Setting, Or, In Some Cases, Lack Thereof
The industry’s angst is growing several months after CMS announced a plan to task contractors with independently setting regional payments for more than 100 new molecular diagnostic codes. A breakdown in the process so far, stakeholders say, could have a lasting impact on small, venture-backed labs.
People In Brief
AdvaMed elects new board members; AliveCor gets new president and CEO; PCORI appoints device and diagnostic reps for advisory panel on health assessments; more People In Brief.